Rybelsus® (semaglutide) tablets is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
Rybelsus® (semaglutide) tablets
Choose an area of interest below to access videos featuring specific information about Rybelsus®.
Pharmacology
-
Rybelsus® Mechanism of Action
This video discusses the mechanism of action of Rybelsus®.
-
Rybelsus® Mechanism of Absorption
This video discusses the mechanism of absorption of Rybelsus®.
-
Pharmacokinetic, Pharmacodynamic (PK/PD) & Dosing Considerations for Rybelsus®
This video describes PK/PD considerations that can impact the dosing of Rybelsus®.
-
Drug Interactions with Rybelsus®
This video reviews potential drug-drug interactions with Rybelsus®.
Glycemic Control Trials
Specific Population Studies
The search will retrieve any scientific documents from the medical information database where the search terms match either the title or content of the document. The response(s) are not intended to offer recommendations for administering Novo Nordisk products in a manner inconsistent with approved labeling. To access the Prescribing Information for Novo Nordisk products, please click here.
Search for Letters
Find documents for this product by entering your search terms in the box below.
Have a Question?
Request information directly from the Novo Nordisk
Medical Information department.
Have a Question?
All fields required.